TrialFrontiers in immunology2024

Optimizing treatment outcomes: immune tolerance induction in Pompe disease patients undergoing enzyme replacement therapy.

Hui-An Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.